newsfilter
← Latest News
GlobeNewswire·

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2026 Results

Differentiated ²¹²Pb radiopharmaceutical platform designed to optimize tumor killing, safety, patient convenience and supply scalabilityThree clinical-stage oncology programs advancing across neuroendocrine tumors,